Pembrolizumab and EDP1503 in Advanced Melanoma

Clinical trial NCT03595683 · TERMINATED

Trial details

NCT number: NCT03595683
Sponsor: University of Chicago
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Melanoma

Start date: 2018-10-02
Primary completion: 2025-07-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.